Comparative expression of pro-inflammatory and apoptotic biosignatures in chronic HBV-infected patients with and without liver cirrhosis. (December 2021)
- Record Type:
- Journal Article
- Title:
- Comparative expression of pro-inflammatory and apoptotic biosignatures in chronic HBV-infected patients with and without liver cirrhosis. (December 2021)
- Main Title:
- Comparative expression of pro-inflammatory and apoptotic biosignatures in chronic HBV-infected patients with and without liver cirrhosis
- Authors:
- Barathan, Muttiah
Riazalhosseini, Behnaz
Iyadorai, Thevambiga
Vellasamy, Kumutha Malar
Vadivelu, Jamuna
Chang, Li-Yen
Zulpa, Ahmad Khusairy
Larsson, Marie
Shankar, Esaki M.
Mohamed, Rosmawati - Abstract:
- Abstract: The interplay of immune mediators is paramount to optimal host anti-viral immune responses, especially against chronic hepatitis B virus (HBV) infection. Here, we investigated the dynamic changes in host immune responses in chronic HBV-infected individuals with and without liver cirrhosis by examining the signatures of apoptosis and plasma levels of pro-inflammatory cytokines, chemokines, and cytotoxic proteins. A total of 40 chronic HBV patients with and without liver cirrhosis were studied for plasma levels of immune mediators, and signatures of apoptosis in peripheral blood mononuclear cells (PBMCs). The intracellular concentrations of reactive oxygen species (ROS) in patients with chronic HBV with liver cirrhosis was relatively higher as compared to chronic HBV patients. The onset of apoptosis was sustained due to ongoing liver inflammation in concert with plasma TNF-α and IL-6 levels. Plasma VEGF was upregulated among chronic HBV patients with liver cirrhosis, whereas CCL2, CCL5 and granzyme B levels were down-regulated. High levels of ROS, IL-6 and TNF-α correlated with ongoing inflammation among chronic HBV patients with liver cirrhosis, which likely attributed to the expression of biosignatures of apoptosis and activation in immune cells. Highlights: The intracellular concentrations of reactive oxygen species (ROS) in patients with chronic HBV with liver cirrhosis was relatively higher as compared to chronic HBV patients. The onset of apoptosis wasAbstract: The interplay of immune mediators is paramount to optimal host anti-viral immune responses, especially against chronic hepatitis B virus (HBV) infection. Here, we investigated the dynamic changes in host immune responses in chronic HBV-infected individuals with and without liver cirrhosis by examining the signatures of apoptosis and plasma levels of pro-inflammatory cytokines, chemokines, and cytotoxic proteins. A total of 40 chronic HBV patients with and without liver cirrhosis were studied for plasma levels of immune mediators, and signatures of apoptosis in peripheral blood mononuclear cells (PBMCs). The intracellular concentrations of reactive oxygen species (ROS) in patients with chronic HBV with liver cirrhosis was relatively higher as compared to chronic HBV patients. The onset of apoptosis was sustained due to ongoing liver inflammation in concert with plasma TNF-α and IL-6 levels. Plasma VEGF was upregulated among chronic HBV patients with liver cirrhosis, whereas CCL2, CCL5 and granzyme B levels were down-regulated. High levels of ROS, IL-6 and TNF-α correlated with ongoing inflammation among chronic HBV patients with liver cirrhosis, which likely attributed to the expression of biosignatures of apoptosis and activation in immune cells. Highlights: The intracellular concentrations of reactive oxygen species (ROS) in patients with chronic HBV with liver cirrhosis was relatively higher as compared to chronic HBV patients. The onset of apoptosis was sustained due to ongoing liver inflammation in concert with plasma TNF-α and IL-6 levels. Plasma VEGF was upregulated among chronic HBV patients with liver cirrhosis, whereas CCL2, CCL5 and granzyme B levels were down-regulated. High levels of ROS, IL-6 and TNF-α correlated with ongoing inflammation among chronic HBV patients with liver cirrhosis, which likely attributed to the expression of biosignatures of apoptosis and activation in immune cells. … (more)
- Is Part Of:
- Microbial pathogenesis. Volume 161:Part A(2021)
- Journal:
- Microbial pathogenesis
- Issue:
- Volume 161:Part A(2021)
- Issue Display:
- Volume 161, Issue 1 (2021)
- Year:
- 2021
- Volume:
- 161
- Issue:
- 1
- Issue Sort Value:
- 2021-0161-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-12
- Subjects:
- Chemokine -- Apoptosis -- Inflammation -- ROS -- Cirrhosis -- Viral hepatitis
CCL C–C motif chemokine ligand -- HBV hepatitis B virus -- IL interleukin -- PBMC peripheral blood mononuclear cell -- ROS reactive oxygen species -- TNF-α tumor necrosis factor alpha -- VEGF vascular endothelial growth factor
Pathogenic microorganisms -- Periodicals
Pathology, Molecular -- Periodicals
Communicable Diseases -- microbiology -- Periodicals
Communicable Diseases -- parasitology -- Periodicals
Micro-organismes pathogènes -- Périodiques
Pathologie moléculaire -- Périodiques
Electronic journals
616.9041 - Journal URLs:
- http://www.sciencedirect.com/science/journal/08824010 ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0882-4010;screen=info;ECOIP ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.micpath.2021.105231 ↗
- Languages:
- English
- ISSNs:
- 0882-4010
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5756.955000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 20148.xml